Press release
US Uveitis Treatment Market Size to Reach USD 1.44 Billion by 2032 Driven by Advancements in Biologics and Increasing Prevalence
Uveitis Treatment Market
The market is gaining strong momentum as awareness of ocular inflammatory disorders rises. The adoption of modern imaging technologies, such as optical coherence tomography (OCT) and fluorescein angiography, aids in early detection. A 2024 study published in Ophthalmology reported that widespread screening programs and quick diagnostic tools have enabled earlier intervention, significantly lowering the risk of vision loss. Along with the rising availability of biologic therapies, corticosteroid implants, and immunomodulators, the uveitis treatment market is becoming a vital part of global eye care. This progress drives better patient outcomes and helps preserve vision over the long term.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/uveitis-treatment-market?sai-v
Uveitis Treatment involves therapies and medications used to reduce inflammation and prevent vision loss in patients with uveitis, an inflammatory eye condition affecting the uvea.
Key Players:
=>The major market players in the AbbVie Inc, Bausch Health Companies / Bausch + Lomb, EyePoint Pharmaceuticals, Inc, Santen Pharmaceutical Co., Ltd, Alimera Sciences, Ocular Therapeutix, Inc, Ophthotech Corporation and among others.
Key Developments
-April 2025 : The Phase 3 trial for an oral TYK2/JAK1 inhibitor (brepocitinib) in non-infectious uveitis was launched, following favourable Phase 2 data showing meaningful reductions in inflammation.
-May 2025 : A real-world claims study on non-infectious uveitis in Japan reported detailed treatment patterns and raised awareness of unmet needs for biologic and sustained-delivery therapies.
-January 2025 : An intraocular fluocinolone-acetonide implant gained regulatory approval for chronic non-infectious uveitis of the posterior segment, offering up to 36-month sustained release therapy.
-September 2024 : Top-line results were reported for a global Phase 3 IL-6-inhibitor intravitreal candidate (vamikibart) targeting uveitic macular oedema and non-infectious uveitis, paving way for regulatory submission.
Recent Mergers & Strategic Moves
-June 2024 : Ophthalmology-focused pharmaceutical company ANI Pharmaceuticals acquired Alimera Sciences (including its YUTIQ and ILUVIEN implants), bolstering its uveitis and posterior-segment inflammation portfolio.
-2025 : Japanese firms increased licensing and co-development partnerships for intravitreal implants and biologic therapies for uveitis, aiming to localize manufacturing and speed access in Asia-Pacific.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=uveitis-treatment-market?sv
Key Segments:
➥ By Type: Anterior, Intermediate, Posterior, Panuveitis
➥ By Drug Class: Corticosteroids, Immunosuppressants, Monoclonal Antibodies, Antibiotics, Others
➥ By Route of Administration: Oral, Intravenous
Market Drivers - Uveitis Treatment Market
Rising Prevalence of Inflammatory Disorders: Increasing incidence of autoimmune and inflammatory diseases such as rheumatoid arthritis and lupus is contributing to more uveitis cases.
Aging Population: Growing elderly demographics are more prone to ocular inflammation, driving treatment demand.
Advancements in Biologics and Drug Delivery: Development of targeted biologic therapies and sustained-release ocular implants is improving treatment effectiveness and compliance.
Early Diagnosis and Awareness: Enhanced imaging technologies, better awareness, and increased access to ophthalmologic care are facilitating earlier and more effective intervention.
Industry Developments - Uveitis Treatment Market
Innovative Drug Delivery Solutions: Introduction of long-acting implants and ocular delivery systems that provide sustained therapeutic effects and convenience.
Shift Toward Targeted Biologic Therapies: Movement from traditional corticosteroids to advanced biologics and immunomodulators with fewer side effects.
Emerging Market Expansion: Growing healthcare infrastructure and investments in ophthalmology services across Asia-Pacific and other developing regions.
Digitalization and Distribution Evolution: Rising use of tele-ophthalmology, online pharmacies, and digital platforms for treatment management and patient monitoring.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/uveitis-treatment-market?sai-v
Research Process:
Both primary and secondary data sources have been used in the Global Uveitis Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Uveitis Treatment Market Size to Reach USD 1.44 Billion by 2032 Driven by Advancements in Biologics and Increasing Prevalence here
News-ID: 4233985 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Geographic information System (GIS) Technology Market | Strategic …
DataM Intelligence has published a new research report on "Geographic information System Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This…
United States Elder Care Services Market to Reach USD 2.33 Billion by 2033, Driv …
The global Elder Care Services Market reached USD 1.34 Billion in 2024 and is projected to reach USD 2.33 Billion by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Brookdale Senior Living launched a new technology-integrated memory care program with AI-powered monitoring and personalized cognitive therapies.
✅ In October 2025, The Centers for Medicare &…
United States Electric Vehicles Battery Recycling Market to Reach USD 20.33 Bill …
The global Electric Vehicles Battery Recycling Market reached USD 1.12 billion in 2024 and is projected to reach USD 20.33 billion by 2032, growing at a CAGR of 43.67% during the forecast period 2025-2032, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Redwood Materials secured a $2 billion Department of Energy loan to expand its EV battery recycling facilities nationwide.
✅ In October 2025, The EPA implemented…
United States Surgical Smoke Evacuation Systems Market Outlook: Growing Awarenes …
The Global Surgical Smoke Evacuation Systems Market reached USD 1.2 billion in 2024 and is expected to grow to USD 3.9 billion by 2032. This represents a CAGR of 15.8% from 2025 to 2032.
The growth is driven by the increasing focus on surgical safety standards, greater awareness of the health risks linked to surgical smoke, and the rising use of minimally invasive procedures. Hospitals and ambulatory surgical centers are…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
